MEDI ASSIST HEALTH SER L
MEDIASSIST · General/Diversified · NSE
₹377
Current Market Price
Fair Value (DCF)
₹292
Discount to FV
-22.5%
Updated just now
YieldIQ Score
59/100
Piotroski F-Score
4/9
Economic Moat
Moderate
Confidence
57%
ROE
10.5%
Debt/Equity
0.06
WACC
11.1%
Market Cap
₹2,813 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
20.0%
Return on capital employed
EV / EBITDA
14.0×
Enterprise multiple
Debt / EBITDA
0.3×
Leverage vs earnings
Interest Coverage
12.1×
EBIT covers interest
Current Ratio
1.49×
Short-term liquidity
Asset Turnover
0.78×
Revenue per ₹ of assets
Revenue CAGR (3Y)
21.7%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹376.6
Bear case
Margin of Safety —
Implied upside -112.8%
Base case
Margin of Safety -41.0%
Implied upside -29.1%
Bull case
Margin of Safety -3.1%
Implied upside -3.0%
Ratio Trends
MEDIASSIST · last 5 annual periods
ROE
10.5%
ROCE
20.0%
Operating Margin
—
Debt / Equity
0.06×
PE
—
EV / EBITDA
—
Historical Financials
MEDIASSIST · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 yfinance | 2023 yfinance | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹390 Cr | ₹502 Cr | ₹633 Cr | ₹723 Cr | ₹905 Cr | +23.4% |
| EBITDA | ₹112 Cr | ₹133 Cr | ₹131 Cr | ₹178 Cr | ₹179 Cr | +12.4% |
| EBIT | — | — | ₹87.6 Cr | — | — | +0.0% |
| PAT | ₹64.2 Cr | ₹74.1 Cr | ₹66.9 Cr | ₹90.9 Cr | ₹87.9 Cr | +8.2% |
| EPS (diluted) | — | — | ₹9.84 | — | — | +0.0% |
| CFO | ₹64.5 Cr | ₹81.1 Cr | ₹66.4 Cr | ₹138 Cr | ₹118 Cr | +16.3% |
| CapEx | ₹-11.8 Cr | ₹-27.7 Cr | ₹-18.4 Cr | ₹-45.8 Cr | ₹-55.9 Cr | — |
| FCF | ₹52.7 Cr | ₹53.4 Cr | ₹48.0 Cr | ₹92.3 Cr | ₹62.1 Cr | +4.2% |
| Total Assets | ₹602 Cr | ₹706 Cr | ₹851 Cr | ₹1158 Cr | ₹1372 Cr | +22.9% |
| Total Debt | ₹27.5 Cr | ₹30.7 Cr | ₹26.3 Cr | ₹204 Cr | ₹54.4 Cr | +18.6% |
| Shareholders' Equity | ₹337 Cr | ₹377 Cr | ₹472 Cr | ₹541 Cr | ₹839 Cr | +25.6% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
MEDIASSIST vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
BLISSGVS BLISSGVS | — | — | Pending | 10.8% | 17.7× |
FISCHER FISCHER MEDICAL VENTURE L | -412.8%-80.5% upside | 40 | Data Limited | 8.1% | — |
 IOLCP IOL CHEM AND PHARMA LTD | -29.2%-22.6% upside | 54 | Above Fair Value | 7.9% | 15.5× |
DCAL DCAL | — | — | Pending | 1.5% | — |
 ORCHPHARMA ORCHID PHARMA LIMITED | -144.5%-59.1% upside | 36 | Data Limited | 7.9% | — |
Click a ticker to view its fair-value analysis.
Dividend History
1 ex-dividend event on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹4.00/sh
Last payout
2024-09-06
₹4.00
Peak payout
₹4.00
Trailing yield
—
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. MEDI ASSIST HEALTH SER L (MEDIASSIST.NS) trades at 376.60 vs a model fair value of 291.79, a gap of -22.5%. Piotroski F-score: 4/9. Moat ...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of MEDIASSIST →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for MEDIASSIST →
Compare
Head-to-head with peers
Compare MEDIASSIST side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse MEDIASSISTNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.